In vivo optical imaging in arthritis-an enlightening future?

Rheumatology

Volumn 49, Issue 8, 2010, Pages 1436-1446

  Gompels, Luke L ^a   Lim, Ngee Han ^a   Vincent, Tonia ^a   Paleolog, Ewa M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Autofluorescence; Experimental arthritis; Fluorescence; Molecular imaging; Near infrared; Optical imaging

Indexed keywords

DYE; PROTEINASE; QUANTUM DOT;

ARTHRITIS; BIOLUMINESCENCE; COMPUTER; ENZYME ACTIVITY; FLUORESCENCE IMAGING; HUMAN; IN VIVO STUDY; INFLAMMATION; MOLECULAR IMAGING; NONHUMAN; OPTICAL TOMOGRAPHY; OPTICS; PRIORITY JOURNAL; REVIEW; TOMOGRAPHY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; DIAGNOSTIC IMAGING; IMAGING, THREE-DIMENSIONAL; MODELS, ANIMAL; TOMOGRAPHY, OPTICAL;

EID: 77954715126     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq012     Document Type: Review

References (100)

1. Biswal S, Resnick DL, Hoffman JM, Gambhir SS. Molecular imaging: integration of molecular imaging into the musculoskeletal imaging practice. Radiology 2007; 244:651-71.
2. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature 2008;452:580-9.
3. Taylor PC. The value of sensitive imaging modalities in rheumatoid arthritis. Arthritis Res Ther 2003;5:210-3.
4. Contag CH, Bachmann MH. Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 2002;4:235-60.
5. Spibey CA, Jackson P, Herick K. A unique charge-coupled device/xenon arc lamp based imaging system for the accurate detection and quantitation of multicolour fluorescence. Electrophoresis 2001;22:829-36.
6. Mahmood U, Weissleder R. Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther 2003;2:489-96.
7. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, Benaron DA. Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 1995;18: 593-603.
8. Chen J, Tung CH, Mahmood U et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 2002; 105:2766-71.
9. Niedre MJ, de Kleine RH, Aikawa E, Kirsch DG, Weissleder R, Ntziachristos V. Early photon tomography allows fluorescence detection of lung carcinomas and disease progression in mice in vivo. Proc Natl Acad Sci USA 2008;105:19126-31.
10. Ntziachristos V, Ripoll J, Wang LV, Weissleder R. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol 2005;23:313-20.
11. Tsien RY. Constructing and exploiting the fluorescent protein paintbox (Nobel Lecture). Angew Chem Int Ed Engl 2009.
12. Winnard PT Jr, Kluth JB, Raman V. Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer. Neoplasia 2006;8: 796-806.
13. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17:545-80.
14. Kovar JL, Simpson MA, Schutz-Geschwender A, Olive DM. A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models. Anal Biochem 2007;367:1-12.
15. Adams KE, Ke S, Kwon S et al. Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt 2007;12: 024017.
16. Kelloff GJ, Krohn KA, Larson SM et al. The progress and promise of molecular imaging probes in oncologic drug development. Clin Cancer Res 2005;11:7967-85.
17. Ballou B, Fisher GW, Waggoner AS et al. Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies. Cancer Immunol Immunother 1995;41:257-63.
18. Kovar JL, Johnson MA, Volcheck WM, Chen J, Simpson MA. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol 2006;169:1415-26.
19. Koyama Y, Hama Y, Urano Y, Nguyen DM, Choyke PL, Kobayashi H. Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu. Clin Cancer Res 2007;13:2936-45.
20. Rosenthal EL, Kulbersh BD, King T, Chaudhuri TR, Zinn KR. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts. Mol Cancer Ther 2007;6: 1230-8.
21. Sampath L, Kwon S, Ke S et al. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med 2007;48:1501-10.
22. Xu H, Baidoo K, Gunn AJ et al. Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging. J Med Chem 2007;50:4759-65.
23. Gleysteen JP, Newman JR, Chhieng D, Frost A, Zinn KR, Rosenthal EL. Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head Neck 2008;30:782-9.
24. Withrow KP, Newman JR, Skipper JB et al. Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts. Technol Cancer Res Treat 2008;7:61-6.
25. Fidarova EF, El-Emir E, Boxer GM et al. Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy. Clin Cancer Res 2008;14: 2639-46.
26. Newman JR, Gleysteen JP, Baranano CF et al. Stereomicroscopic fluorescence imaging of head and neck cancer xenografts targeting CD147. Cancer Biol Ther 2008;7:1063-70.
27. Kaushal S, McElroy MK, Luiken GA et al. Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. J Gastrointest Surg 2008;12:1938-50.
28. McElroy M, Hayashi K, Garmy-Susini B et al. Fluorescent LYVE-1 antibody to image dynamically lymphatic trafficking of cancer cells in vivo. J Surg Res 2009;151:68-73.
29. Lisy MR, Goermar A, Thomas C et al. In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice. Radiology 2008; 247:779-87.
30. Zou P, Xu S, Wang A et al. Near-infrared fluorescence labeled anti-tag-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Mol Pharm 2009.
31. Urano Y, Asanuma D, Hama Y et al. Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat Med 2009;15:104-9.
32. Joyce JA, Baruch A, Chehade K et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 2004;5: 443-53.
33. Sheth RA, Upadhyay R, Stangenberg L, Sheth R, Weissleder R, Mahmood U. Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical model. Gynecol Oncol 2009;112:616-22.
34. Blum G, Weimer RM, Edgington LE, Adams W, Bogyo M. Comparative assessment of substrates and activity based probes as tools for non-invasive optical imaging of cysteine protease activity. PLoS One 2009;4:e6374.
35. Gounaris E, Tung TH, Restaino C et al. Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth. PLoS One 2008;3:e2916.
36. Blum G, von Degenfeld G, Merchant MJ, Blau HM, Bogyo M. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat Chem Biol 2007;3:668-77.
37. Melancon MP, Wang W, Wang Y et al. A novel method for imaging in vivo degradation of poly(L-glutamic acid), a biodegradable drug carrier. Pharm Res 2007;24:1217-24.
38. Figueiredo JL, Alencar H, Weissleder R, Mahmood U. Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer. Int J Cancer 2006;118:2672-7.
39. Scherer RL, VanSaun MN, McIntyre JO, Matrisian LM. Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Mol Imaging 2008; 7:118-31.
40. Chen J, Tung CH, Allport JR, Chen S, Weissleder R, Huang PL. Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. Circulation 2005;111:1800-5.
41. Deguchi JO, Aikawa M, Tung CH et al. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 2006;114:55-62.
42. Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, Tsien RY. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci USA 2004;101:17867-72.
43. Tak PP, Taylor PC, Breedveld FC et al. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1077-81.
44. Guillemin F, Billot L, Boini S, Gerard N, Odegaard S, Kvien TK. Reproducibility and sensitivity to change of 5 methods for scoring hand radiographic damage in patients with rheumatoid arthritis. J Rheumatol 2005;32: 778-86.
45. van der Heijde DM, van Leeuwen MA, van Riel PL, van de Putte LB. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). J Rheumatol 1995;22:1792-6.
46. Menger MD, Lehr HA. Scope and perspectives of intravital microscopy-bridge over from in vitro to in vivo. Immunol Today 1993;14:519-22.
47. Veihelmann A, Szczesny G, Nolte D, Krombach F, Refior HJ, Messmer K. A novel model for the study of synovial microcirculation in the mouse knee joint in vivo. Res Exp Med 1998;198:43-54.
48. Veihelmann A, Harris AG, Krombach F, Schutze E, Refior HJ, Messmer K. In vivo assessment of synovial microcirculation and leukocyte-endothelial cell interaction in mouse antigen-induced arthritis. Microcirculation 1999; 6:281-90.
49. Schmitt-Sody M, Landes J, Zysk SP et al. Quantitative assessment of angiogenesis in murine antigen-induced arthritis by intravital fluorescence microscopy. J Vasc Res 2003;40:460-6.
50. Sehnert B, Gierer P, Ibrahim S et al. Modulation of granulocyte-endothelium interactions by antileukoproteinase: inhibition of anti-type II collagen antibody-induced leukocyte attachment to the synovial endothelium. Arthritis Res Ther 2006;8:R95.
51. Levick JR. Permeability of rheumatoid and normal human synovium to specific plasma proteins. Arthritis Rheum 1981;24:1550-60.
52. Hansch A, Frey O, Hilger I et al. Diagnosis of arthritis using near-infrared fluorochrome Cy5.5. Invest Radiol 2004;39: 626-32.
53. Fischer T, Gemeinhardt I, Wagner S et al. Assessment of unspecific near-infrared dyes in laser-induced fluorescence imaging of experimental arthritis. Acad Radiol 2006; 13:4-13.
54. Andersson SE, Johansson A, Lexmuller K, Ekstrom GM. Physiological characterization of mBSA antigen induced arthritis in the rat. II. Joint blood flow, glucose metabolism, and cell proliferation. J Rheumatol 1998;25:1778-84.
55. Palframan R, Airey M, Moore A, Vugler A, Nesbitt A. Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis. J Immunol Methods 2009;348:36-41.
56. Hansch A, Sauner D, Hilger I et al. Noninvasive diagnosis of arthritis by autofluorescence. Invest Radiol 2003;38: 578-83.
57. Hansch A, Sauner D, Hilger I et al. In vivo imaging of experimental arthritis with near-infrared fluorescence. Arthritis Rheum 2004;50:961-7.
58. Chen WT, Mahmood U, Weissleder R, Tung CH. Arthritis imaging using a near-infrared fluorescence folate-targeted probe. Arthritis Res Ther 2005;7:R310-7.
59. Simon GH, Daldrup-Link HE, Kau J et al. Optical imaging of experimental arthritis using allogeneic leukocytes labeled with a near-infrared fluorescent probe. Eur J Nucl Med Mol Imaging 2006;33:998-1006.
60. Chapman PT, Jamar F, Keelan ET, Peters AM, Haskard DO. Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. Arthritis Rheum 1996;39:1371-5.
61. Jamar F, Houssiau FA, Devogelaer JP et al. Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. Rheumatology 2002;41: 53-61.
62. Marshall D, Haskard DO. Clinical overview of leukocyte adhesion and migration: where are we now? Semin Immunol 2002;14:133-40.
63. Lang A, Horler D, Baici A. The relative importance of cysteine peptidases in osteoarthritis. J Rheumatol 2000; 27:1970-9.
64. Lai WF, Chang CH, Tang Y, Bronson R, Tung CH. Early diagnosis of osteoarthritis using cathepsin B sensitive near-infrared fluorescent probes. Osteoarthritis Cartilage 2004;12:239-44.
65. Bhaumik S, Gambhir SS. Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc Natl Acad Sci USA 2002;99:377-82.
66. Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 1999;17: 375-8.
67. Wunder A, Tung CH, Muller-Ladner U, Weissleder R, Mahmood U. In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum 2004;50:2459-65.
68. Izmailova ES, Paz N, Alencar H et al. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis. Arthritis Rheum 2007;56: 117-28.
69. Wilson T, Hastings JW. Bioluminescence. Annu Rev Cell Dev Biol 1998;14:197-230.
70. Zhao H, Doyle TC, Coquoz O, Kalish F, Rice BW, Contag CH. Emission spectra of bioluminescent reporters and interaction with mammalian tissue determine the sensitivity of detection in vivo. J Biomed Opt 2005;10:41210.
71. Nakatsu T, Ichiyama S, Hiratake J et al. Structural basis for the spectral difference in luciferase bioluminescence. Nature 2006;440:372-6.
72. Carlsen H, Moskaug JO, Fromm SH, Blomhoff R. In vivo imaging of NF-kappa B activity. J Immunol 2002;168: 1441-6.
73. Nakajima A, Seroogy CM, Sandora MR et al. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest 2001;107: 1293-301.
74. Shu X, Royant A, Lin MZ et al. Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science 2009;324:804-7.
75. Razansky D, Distel M, Vinegoni C et al. Multispectral opto-acoustic tomography of deep-seated fluorescent proteins in vivo. Nat Photonics 2009;3:412-7.
76. Walling MA, Novak JA, Shepard JR. Quantum dots for live cell and in vivo imaging. Int J Mol Sci 2009;10: 441-91.
77. Chan WC, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998;281: 2016-8.
78. Zhang Q, Li Y, Tsien RW. The dynamic control of kiss-and-run and vesicular reuse probed with single nanoparticles. Science 2009;323:1448-53.
79. Buono C, Anzinger JJ, Amar M, Kruth HS. Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions. J Clin Invest 2009;119:1373-81.
80. Conklin MW, Provenzano PP, Eliceiri KW, Sullivan R, Keely PJ. Fluorescence lifetime imaging of endogenous fluorophores in histopathology sections reveals differences between normal and tumor epithelium in carcinoma in situ of the breast. Cell Biochem Biophys 2009;53: 145-57.
81. Bloch S, Lesage F, McIntosh L, Gandjbakhche A, Liang K, Achilefu S. Whole-body fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in mice. J Biomed Opt 2005;10:054003.
82. McCormack E, Micklem DR, Pindard LE et al. In vivo optical imaging of acute myeloid leukemia by green fluorescent protein: time-domain autofluorescence decoupling, fluorophore quantification, and localization. Mol Imaging 2007;6:193-204.
83. Yang J, Lim EK, Lee HJ et al. Fluorescent magnetic nanohybrids as multimodal imaging agents for human epithelial cancer detection. Biomaterials 2008;29: 2548-55.
84. Shan L, Wang S, Sridhar R, Bhujwalla ZM, Wang PC. Dual probe with fluorescent and magnetic properties for imaging solid tumor xenografts. Mol Imaging 2007;6:85-95.
85. Ogawa M, Kosaka N, Choyke PL, Kobayashi H. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Res 2009;69:1268-72.
86. Levi J, Cheng Z, Gheysens O et al. Fluorescent fructose derivatives for imaging breast cancer cells. Bioconjug Chem 2007;18:628-34.
87. Huang YF, Chang HT, Tan W. Cancer cell targeting using multiple aptamers conjugated on nanorods. Anal Chem 2008;80:567-72.
88. Boswell CA, Eck PK, Regino CA et al. Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers. Mol Pharm 2008;5:527-39.
89. Ntziachristos V. Fluorescence molecular imaging. Annu Rev Biomed Eng 2006;8:1-33.
90. Scheinecker C. Application of in vivo microscopy: evaluating the immune response in living animals. Arthritis Res Ther 2005;7:246-52.
91. Denk W, Strickler JH, Webb WW. Two-photon laser scanning fluorescence microscopy. Science 1990;248: 73-6.
92. Slakter JS, Yannuzzi LA, Guyer DR, Sorenson JA, Orlock DA. Indocyanine-green angiography. Curr Opin Ophthalmol 1995;6:25-32.
93. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960;39:592-600.
94. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003;9:123-8.
95. Ishizawa T, Fukushima N, Shibahara J et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer 2009;115:2491-504.
96. Gotoh K, Yamada T, Ishikawa O et al. A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation. J Surg Oncol 2009;100:75-9.
97. Troyan SL, Kianzad V, Gibbs-Strauss SL et al. The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 2009;16:2943-52.
98. Tagaya N, Yamazaki R, Nakagawa A et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg 2008;195:850-3.
99. Sevick-Muraca EM, Sharma R, Rasmussen JC et al. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology 2008;246: 734-41.
100. Ntziachristos V, Ripoll J, Weissleder R. Would near-infrared fluorescence signals propagate through large human organs for clinical studies? Opt Lett 2002; 27:333-5.